Denise Ruffner, VP Business Development and Commercial Operations Worldwide, Haiqu – Interview Series

Denise Ruffner, VP Business Development and Commercial Operations Worldwide at Haiqu, is a seasoned technology executive with extensive experience commercializing quantum computing and other emerging technologies. At Haiqu, she leads business development and worldwide expansion, building on previous leadership roles including Chief Business Officer at Atom Computing and Cambridge Quantum Computing, Vice President of Business…

Read More

Novo Nordisk Taps Anthropic’s Claude to Speed Drug Discovery

Novo Nordisk and Anthropic announced a collaboration on September 16, 2026, under which the drugmaker will use Anthropic’s frontier AI models and test the Claude Science workbench in specific research and development workflows, with the stated goal of accelerating the discovery and development of new medicines. Collaboration Scope and Governance In the announcement, datelined Bagsværd,…

Read More

New AI technique could make minimally invasive surgeries safer and more precise

Researchers created a new technique that accurately and rapidly matches X-rays captured during surgery with a patient’s preoperative 3D medical scan. This method could make it easier for clinicians to precisely pilot minimally invasive surgical tools, leading to faster and safer procedures. Clinicians perform many minimally invasive surgeries using real-time X-rays to help them steer…

Read More

Cohere Signs Definitive Combination Agreement with Aleph Alpha

Cohere and Aleph Alpha announced on September 16, 2026 that they have signed a definitive business combination agreement, formalizing the planned combination the companies first disclosed in April 2026. The unified company will operate globally as Cohere and will be dual-headquartered in Berlin and Toronto. The transaction remains subject to final regulatory approvals and is…

Read More
Back To Top